Diabetes Medications May Lower Risk of Dementia and Parkinson's Disease
A recent study suggests that a class of diabetes medications could be linked to a reduced risk of developing dementia ...
devdiscourse8h
Diabetes Drugs May Lower Risk of Dementia and Parkinson’s, Study Finds
Diabetes medications, specifically sodium-glucose cotransporter-2 (SGLT2) inhibitors, may be linked to a decreased risk of ...
health.economictimes.indiatimes8h
Some diabetes medications linked to lower dementia, Parkinson's disease risk
Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...
Daily Independent11h
Medications include strong warnings about perineum infections
ROACH: Why is it that certain medications warn against possible infections in the perineum? I saw an ad for Jardiance that warned against this. Just now, I viewed a Farxiga ad, and there was the same ...
HealthDay on MSN16h
Some Diabetes Meds Could Lower Odds for Dementia, Parkinson's
A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.
Type 2 drugs could lower dementia, Parkinson's disease risk
Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...
Daily18h
SGLT2 inhibitors tied to lower risk of dementia, Parkinson’s disease, suggests study
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson’s disease, according to a study ...
HealthDay on MSN1d
SGLT2i Use Linked to Lower Risk for Neurodegenerative Disease in T2DM
Hae Kyung Kim, M.D., from the Yonsei University College of Medicine in Seoul, South Korea, and colleagues examined the ...
McKnight's Long-Term Care News1d
SGLT2 inhibitors reduce dementia, Parkinson’s disease risk: study
Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs also known as gliflozins, could lower the risk ...